PMC:7441777 / 238-2000
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T3 | 372-375 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T4 | 386-389 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T5 | 429-432 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T6 | 591-594 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 44-52 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 68-115 | Disease | denotes | Severe Acute Respiratory Syndrome Coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 117-125 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 235-243 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 362-370 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 418-426 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 801-809 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 853-861 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 1753-1761 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 135-136 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 595-602 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T3 | 681-682 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 879-880 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T5 | 1090-1093 | http://purl.obolibrary.org/obo/CLO_0009325 | denotes | TF1 |
T6 | 1253-1259 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T7 | 1283-1284 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 1536-1537 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 203-207 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T6 | 283-287 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T7 | 301-305 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T8 | 343-351 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
T9 | 481-495 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T10 | 481-490 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T11 | 491-495 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 541-552 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T13 | 622-633 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T14 | 784-795 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T15 | 892-903 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T16 | 1072-1076 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T17 | 1078-1088 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T18 | 1096-1106 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T19 | 1112-1119 | Chemical | denotes | gallate | http://purl.obolibrary.org/obo/CHEBI_16918 |
T20 | 1128-1138 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T21 | 1142-1149 | Chemical | denotes | gallate | http://purl.obolibrary.org/obo/CHEBI_16918 |
T22 | 1158-1183 | Chemical | denotes | theaflavin 3,3'-digallate | http://purl.obolibrary.org/obo/CHEBI_136608 |
T23 | 1158-1168 | Chemical | denotes | theaflavin | http://purl.obolibrary.org/obo/CHEBI_136609 |
T24 | 1174-1183 | Chemical | denotes | digallate | http://purl.obolibrary.org/obo/CHEBI_17866 |
T25 | 1185-1188 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T26 | 1191-1201 | Chemical | denotes | hesperidin | http://purl.obolibrary.org/obo/CHEBI_28775 |
T27 | 1203-1216 | Chemical | denotes | quercetagetin | http://purl.obolibrary.org/obo/CHEBI_8695 |
T28 | 1222-1231 | Chemical | denotes | myricetin | http://purl.obolibrary.org/obo/CHEBI_18152|http://purl.obolibrary.org/obo/CHEBI_58395 |
T30 | 1335-1339 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T31 | 1353-1356 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T32 | 1465-1467 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
T34 | 1675-1679 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T35 | 1693-1696 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 429-444 | http://purl.obolibrary.org/obo/GO_0039703 | denotes | RNA replication |
T2 | 731-742 | http://purl.obolibrary.org/obo/GO_0042592 | denotes | homeostasis |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
44 | 402-406 | Gene | denotes | RdRp | Gene:43740578 |
45 | 577-581 | Gene | denotes | RdRp | Gene:43740578 |
46 | 812-816 | Gene | denotes | RdRp | Gene:43740578 |
47 | 1035-1039 | Gene | denotes | RdRp | Gene:43740578 |
48 | 1151-1155 | Gene | denotes | TF2b | Gene:2959 |
49 | 1268-1272 | Gene | denotes | RdRp | Gene:43740578 |
50 | 1347-1351 | Gene | denotes | TF2b | Gene:2959 |
51 | 1406-1410 | Gene | denotes | RdRp | Gene:43740578 |
52 | 1687-1691 | Gene | denotes | TF2b | Gene:2959 |
53 | 1709-1713 | Gene | denotes | RdRp | Gene:43740578 |
54 | 68-115 | Species | denotes | Severe Acute Respiratory Syndrome Coronavirus 2 | Tax:2697049 |
55 | 117-127 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
56 | 418-428 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
57 | 801-811 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
58 | 541-552 | Chemical | denotes | polyphenols | MESH:D059808 |
59 | 622-633 | Chemical | denotes | polyphenols | MESH:D059808 |
60 | 784-795 | Chemical | denotes | polyphenols | MESH:D059808 |
61 | 892-903 | Chemical | denotes | polyphenols | MESH:D059808 |
62 | 1072-1076 | Chemical | denotes | EGCG | MESH:C045651 |
63 | 1078-1088 | Chemical | denotes | theaflavin | MESH:C056068 |
64 | 1096-1119 | Chemical | denotes | theaflavin-3’-O-gallate | |
65 | 1128-1149 | Chemical | denotes | theaflavin-3’-gallate | |
66 | 1158-1183 | Chemical | denotes | theaflavin 3,3'-digallate | MESH:C585473 |
67 | 1185-1188 | Chemical | denotes | TF3 | MESH:C585473 |
68 | 1191-1201 | Chemical | denotes | hesperidin | MESH:D006569 |
69 | 1203-1216 | Chemical | denotes | quercetagetin | MESH:C079163 |
70 | 1222-1231 | Chemical | denotes | myricetin | MESH:C040015 |
71 | 1335-1339 | Chemical | denotes | EGCG | MESH:C045651 |
72 | 1468-1472 | Chemical | denotes | PBSA | MESH:C437084 |
73 | 1559-1563 | Chemical | denotes | ADME | |
74 | 1675-1679 | Chemical | denotes | EGCG | MESH:C045651 |
75 | 23-42 | Disease | denotes | Coronavirus disease | MESH:D018352 |
76 | 44-52 | Disease | denotes | COVID-19 | MESH:C000657245 |
77 | 235-243 | Disease | denotes | COVID-19 | MESH:C000657245 |
78 | 362-370 | Disease | denotes | COVID-19 | MESH:C000657245 |
79 | 853-861 | Disease | denotes | COVID-19 | MESH:C000657245 |
80 | 1576-1584 | Disease | denotes | toxicity | MESH:D064420 |
81 | 1753-1761 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T1 | 1090-1093 | GlycoEpitope | denotes | TF1 | http://www.glycoepitope.jp/epitopes/AN0049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-176 | Sentence | denotes | The sudden outburst of Coronavirus disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a massive threat to global public health. |
T8 | 177-244 | Sentence | denotes | Currently, no therapeutic drug or vaccine exists to treat COVID-19. |
T9 | 245-371 | Sentence | denotes | Due to the time taking process of new drug development, drug repurposing might be the only viable solution to tackle COVID-19. |
T10 | 372-503 | Sentence | denotes | RNA‐dependent RNA polymerase (RdRp) catalyzes SARS-CoV-2 RNA replication and hence, is an obvious target for antiviral drug design. |
T11 | 504-603 | Sentence | denotes | Interestingly, several plant-derived polyphenols effectively inhibit the RdRp of other RNA viruses. |
T12 | 604-743 | Sentence | denotes | More importantly, polyphenols have been used as dietary supplementations for a long time and played beneficial roles in immune homeostasis. |
T13 | 744-862 | Sentence | denotes | We were curious to study the binding of polyphenols with SARS-CoV-2 RdRp and assess their potential to treat COVID-19. |
T14 | 863-977 | Sentence | denotes | Herein, we made a library of polyphenols that have shown substantial therapeutic effects against various diseases. |
T15 | 978-1040 | Sentence | denotes | They were successfully docked in the catalytic pocket of RdRp. |
T16 | 1041-1273 | Sentence | denotes | The investigation reveals that EGCG, theaflavin (TF1), theaflavin-3’-O-gallate (TF2a), theaflavin-3’-gallate (TF2b), theaflavin 3,3'-digallate (TF3), hesperidin, quercetagetin, and myricetin strongly bind to the active site of RdRp. |
T17 | 1274-1411 | Sentence | denotes | Further, a 150-ns molecular dynamic simulation revealed that EGCG, TF2a, TF2b, TF3 result in highly stable bound conformations with RdRp. |
T18 | 1412-1517 | Sentence | denotes | The binding free energy components calculated by the MM-PBSA also confirm the stability of the complexes. |
T19 | 1518-1640 | Sentence | denotes | We also performed a detailed analysis of ADME prediction, toxicity prediction, and target analysis for their druggability. |
T20 | 1641-1762 | Sentence | denotes | Overall, our results suggest that EGCG, TF2a, TF2b, TF3 can inhibit RdRp and represent an effective therapy for COVID-19. |